Artiva Biotherapeutics, Inc. Common Stock (ARTV) Insider Trading
- $29,999,976.00
- $69,615.00
- Aug. 15, 2025
- Fred Aslan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 15, 2025 | CEO | 25,500 | $2.73 | Sell | $69,615.00 | |
| July 22, 2024 | Director | 2,083,332 | $12.00 | Buy | $24,999,984.00 | |
| July 22, 2024 | Major Shareholder | 416,666 | $12.00 | Buy | $4,999,992.00 |
Insiders are both buying and selling Artiva Biotherapeutics, Inc. Common Stock stock.
The insider traders at Artiva Biotherapeutics, Inc. Common Stock are: Fred Aslan, Global Strategic Fund I Venbio, and Yong-Jun Huh
The most active insider trader at Artiva Biotherapeutics, Inc. Common Stock is Fred Aslan with 1 trades.
Fred Aslan has sold the most Artiva Biotherapeutics, Inc. Common Stock stock with a total value of $139,230.00.
Yong-Jun Huh has bought the most Artiva Biotherapeutics, Inc. Common Stock stock with a total value of $49,999,968.00.
The most recent insider trade for Artiva Biotherapeutics, Inc. Common Stock was on Aug. 15, 2025.
The single biggest insider buy for Artiva Biotherapeutics, Inc. Common Stock was from Yong-Jun Huh with a total value of $24,999,984.00 on July 22, 2024.
The single biggest insider sell for Artiva Biotherapeutics, Inc. Common Stock was from Fred Aslan with a total value of $69,615.00 on Aug. 15, 2025.